| Literature DB >> 22439817 |
Laura M Riley1, Marta Veses-Garcia, Jeffrey D Hillman, Martin Handfield, Alan J McCarthy, Heather E Allison.
Abstract
BACKGROUND: Shigatoxigenic E. coli are a global and emerging health concern. Shiga toxin, Stx, is encoded on the genome of temperate, lambdoid Stx phages. Genes essential for phage maintenance and replication are encoded on approximately 50% of the genome, while most of the remaining genes are of unknown function nor is it known if these annotated hypothetical genes are even expressed. It is hypothesized that many of the latter have been maintained due to positive selection pressure, and that some, expressed in the lysogen host, have a role in pathogenicity. This study used Change Mediated Antigen Technology (CMAT)™ and 2D-PAGE, in combination with RT-qPCR, to identify Stx phage genes that are expressed in E. coli during the lysogenic cycle.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22439817 PMCID: PMC3342100 DOI: 10.1186/1471-2180-12-42
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
CDS identified by CMAT and location on the Φ24B genome
| Clone | Alignment to Φ24B genome | Aligned CDS | Possible gene |
|---|---|---|---|
| CM1 | 39370-39772 | 38090-40027 | |
| CM2 + CM14 | 17489-18104 | 17559-18086 | |
| CM3 | 2523-2185 | a: 2378-2286 | |
| b: 2507-2379 | |||
| CM4 | 3025-2375 | a: 2545-2375 | |
| b: 2812-2711 | |||
| c: 2911-2840 | |||
| CM5 | 54385-53866 | 53693-53866 | |
| CM6 | 53690-53235 | 53482-53297 | |
| CM7 + CM13 | 55160-55667 | 49148-57571 | |
| CM8 | 38754-39248 | 38460-38954 | |
| CM9 | 2542-2940 | 2248-2646 | |
| CM10 | 35049-34598 | 33695-34702 | |
| CM11 + CM12 | 39573-40016 | 40189-39355 | |
| CM15 | 40137-40506 | 40345-40626 | |
| CM16 | 38041-37623 | 38000-37698 | |
| CM17 | 52465-52147 | 52191-52514 | |
| CM18 | 45227-45877 | 44818-45552 | |
| CM19 | 45610-46100 | 45981-46382 | |
| CM20 | 4098-3676 | 4333-4052 | |
| CM21 | 39305-39919 | 39405-39650 | |
| CM22 | 39875-40526 | 39909-40298 | |
| CM23 | 45713-46232 | a: 45784-45921 | |
| b: 46072-46239 |
Figure 1Schematic representation of the Φ24. Squares symbolise the locations of the CMAT and PAGE CDS identified as well as some of the essential genes involved in the life cycle of the phage. - represents 5 kb. For further details on the gene identities see Tables 1 & 2.
Figure 22D-PAGE images of total cell protein from MC1061/Φ24. IEF on pH range 4-7 (A, C), 5.3-6.5 (B) and 3-5.6 (D). Arrows represent proteins identified as phage encoded; circles represent proteins identified as encoded by E. coli, but not present on corresponding naïve MC1061 gels (data not shown).
Protein identities according to the MASCOT database
| P♯ | Gene name | pI/MW (Da) | Description | Sequencea Coverage (%) | MASCOTb Score | Peptidesc matches | Estimated pI/MW (Da) | MASCOT Database Identified in | |
|---|---|---|---|---|---|---|---|---|---|
| 5.28/33860 | Identical to hypothetical protein p78 from 933 Wd | 32 | 63* | 6 | 5.50/40000 | 1 | |||
| 5.27/17096 | Similar to hypothetical protein p23 from 933 W | 42 | 39 | 5 | 5.00/15000 | 1 | |||
| 5.09/13472 | Similar to hypothetical protein p24 from 933 W | 33 | 55 | 3 | 5.6/8000 | 1 | |||
| 5.14/25800 | Identical to exo of 933 W | 29 | 52 | 5 | 5.5/40000 | 1 | |||
| 5.29/7336 | Not known homologue | 83 | 41 | 2 | 7.00/7000 | 1 | |||
| 5.22/13628 | Identical to hypothetical protein Stx2Ip064e | 38 | 30 | 4 | 7.00/10000 | 1 | |||
| 5.77/34077 | N-acetylneuraminate lyse 2 | 21 | 47 | 4 | 5.3/35000 | 2 | |||
| 5.29/52634 | Glutamate decarboxylase beta | 23 | 57 | 7 | 5.3/35000 | 2 | |||
| 5.58/21121 | Superoxide dismutase [Fe] | 40 | 53 | 6 | 4.00/100000 | 2 | |||
| 8.23/92983 | Nitrate reductase | 14 | 49 | 7 | 5.5/100000 | 2 | |||
| 4.73/47994 | Trigger factor | 24 | 58* | 7 | 3.5/6000 | 2 | |||
| UTI89_C3021 | 4.70/6971 | Hypothetical protein | 70 | 42 | 2 | 5.5/7000 | 2 | ||
| 2FPKA | 5.24/32497 | 6-phosphofructokinase | 23 | 46 | 5 | 5.3/50000 | 2 | ||
| 5.87/40658 | 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase | 16 | 38 | 4 | 5.5/80000 | 2 | |||
| 5.46/99475 | Pyruvate dehydrogenase E1 component | 10 | 60* | 7 | 5.4/100000 | 2 | |||
| 7.63/18294 | BfpK | 54 | 49 | 3 | 6.4/25000 | 2 | |||
| 5.02/12685 | ychN | 46 | 38 | 2 | 5.3/100000 | 2 | |||
| UTI89_C1147 | 5.57/24945 | Hypothetical protein | 15 | 38 | 4 | 5.7/30000 | 2 | ||
| 4.55/40474 | Outer membrane protein | 18 | 44 | 4 | 5.5/40000 | 2 | |||
| ECs1247 | 4.74/25144 | Hypothetical protein | 26 | 39 | 5 | 6.5/35000 | 2 | ||
| UTI89_C2748 | 10.19/10724 | Hypothetical protein | 44 | 50 | 4 | 6.4/8000 | 2 | ||
| 5.79/93112 | Nitrate reductase (NAD(P)H) Subunit | 10 | 53 | 8 | 5.3/100000 | 2 | |||
| 5.65/15401 | yagP protein | 36 | 43 | 3 | 5.3/10000 | 2 | |||
| 5.69/23342 | RhsF | 18 | 42 | 4 | 5.69/8000 | 2 |
Table represents matches to E. coli proteins in the MASCOT database and matches to Φ24B proteins in the University of Liverpool local MASCOT database
a percentage of sequence of the matched protein that is covered by the experimental MS.
b logarithm of the probability that the match between the experimental data and a protein sequence in the database is a random event.
c number of peptides that match the protein in the database
d 933 W is an Stx2 phage described by Plunkett et al. [16].
e Stx2 is an Stx2 phage described by Sato et al. [20].
*represents significant matches (p-value < 0.05)
1 University of Liverpool local MASCOT database; 2 general MASCOT database
Figure 3Graph depicting gene expression profiles before and following norfloxacin induction. Panel A: Control Genes. CI, marker gene for lysogeny-restricted expression; Cro and Q, marker genes for early induction response; Ter and Cap, marker genes for late gene expression; GyrB and 16S, marker genes for the cellular response. Panel B: Expression profiles of the prophage genes identified by CMAT. Panel C: Expression profiles of the genes identified by 2D-PAGE analyses of the lysogen. The Y axis represents gene copy number per 300 ng of RNA; the X axis represents time (min). Time -60 refers to the samples taken before induction and represents the lysogen population, Time 0 represents samples taken at the beginning of the recovery time, Time 10, 10 min after recovery, etc. The experiment was run using biological replicates, but due to the asynchronicity of induction across these experiments the data from a representative single biological replicate are shown.
Distribution of the proteins identified by CMAT and 2D-PAGE across phage genomes
| Gene | Other Stx phages carrying the proteins in the study (identity) | Accession number | Other phages | Accession number |
|---|---|---|---|---|
| CM1 | Stx2 converting phage II (99%) | |||
| phage VT2-Sakai (99%) | ||||
| phage 933 W (99%) | ||||
| Stx1 converting phage (99%) | ||||
| phage BP-933 W (99%) | ||||
| phage VT2phi_272 (99%) | ||||
| phage Min27(100%) | ||||
| CM2 | Stx2 converting phage II (100%) | |||
| phage VT2-Sakai (100%) | ||||
| phage Min27 (100%) | ||||
| phage HK97 (99%) | ||||
| phage Lahn2 (99%) | ||||
| phage Lahn3 (98%) | ||||
| phage 2851 (99%) | ||||
| phage CP-1639(99%) | ||||
| prophage CP-933 V(99%) | ||||
| Phage Nil2 (99%)(99%) | ||||
| Stx1 converting phage (99%) | ||||
| Phage CP-1639 (99%) | ||||
| Phage YYZ-2088 (99%) | ||||
| Stx2-converting phage 1717 (99%) | ||||
| CM5 | phage Min27 (100%) | |||
| Stx2 converting phage II(100%) | ||||
| Stx2 converting phage I(100%) | ||||
| phage VT2-Sakai (100%) | ||||
| phage 933 W (100%) | ||||
| phage VT2phi_272 (100%) | ||||
| CM7 | phage VT2-Sakai (99%) | |||
| Stx1 converting phage (99%) | ||||
| Phage VT2phi_272 (97%) | ||||
| Phage 933 W (97%) | ||||
| Stx2 converting phage I (97%) | ||||
| Stx2 converting phage II(97%) | ||||
| Phage BP-933 W (97%) | ||||
| Stx2 converting phage 86 (91%) | ||||
| Phage Min27 (97%) | ||||
| CM18 | phage VT2-Sakai (100%) | |||
| Stx1 converting phage (100%) | ||||
| Phage 933 W (100%) | ||||
| Stx2 converting phage I (100%) | ||||
| Stx2 converting phage II (100%) | ||||
| Phage BP-933 W (100%) | ||||
| Stx2 converting phage 86 (97%) | ||||
| Phage Min27 (100%) | ||||
| P1 | Stx2 converting phage II (99%) | Phage phiV10 (78%) | ||
| Stx2 converting phage I (99%) | ||||
| Phage 933 W (99%) | ||||
| Phage BP-933 W (99%) | ||||
| phage VT2-Sakai (99%) | ||||
| Phage Min27 (96%) | ||||
| Stx2-converting phage 86 (96%) | ||||
| Phage BP-4795 (96%) | ||||
| phage CP-1639 (74%) | ||||
| P2 | Stx2 converting phage I (100%) | |||
| Phage 933 W (100%) | bacteriophage SE1 (86%) | |||
| Phage BP-933 W (100%) | ||||
| Phage Min27 (100%) | ||||
| Stx2-converting phage 86 (100%) | ||||
| P3 | Stx2 converting phage I (100%) | |||
| Phage 933 W (100%) | ||||
| Stx2-converting phage 86 (100%) | ||||
| Phage Min27 (100%) | ||||
| Phage BP-933 W (100%) | ||||
| P4 | Phage 933 W (100%) | Phage lambda (98%) | ||
| Phage BP-933 W (100%) | ||||
| Prophage CP-933 V (100%) | ||||
| Stx2 converting phage I (100%) | ||||
| Phage VT1-Sakai (100%) | ||||
| Phage YYZ-2008 (99%) | ||||
| Stx2-converting phage 1717 (98%) | ||||
| prophage CP-933 K (98%) | ||||
| phage BP-4795 (98%) | ||||
| phage Min27 (99%) | ||||
| P5 | Stx2 converting phage I (100%) | |||
| Phage 933 W (100%) | ||||
| Stx2 converting phage II (100%) | ||||
| Stx2-converting phage 1717 (98%) | ||||
| phage 2851 (98%) | ||||
| Phage BP-4795 (97%) | ||||
| P6 | Stx2 converting phage I (99%) | |||
| Stx2 converting phage II (99%) | ||||
| phage VT2phi_272 (99%) | ||||
| phage Min27 (99%) | ||||
| phage VT2-Sakai (99%) | ||||
| Stx1 converting phage (99%) | ||||
| Stx2-converting phage 86 (96%) | ||||
Bacterial strains, plasmid and phages used in the study
| Relevant Genotype | Reference | |
|---|---|---|
| F- | Invitrogen, Paisley, U.K. | |
| F- Δ( | [ | |
| F- | [ | |
| F- | Invitrogen, Paisley, U.K. | |
| Invitrogen, Paisley, U.K. | ||
| Expression vector with T7 promoter, KanR, TetR, | Novagen, Notts, UK | |
| Stx2-phage, Δ | [ |